In recent study, CEACAM6 was reported as predictive for endocrine therapy resistance and a unique mediator of migration and invasion of drug-resistant estrogen-deprived breast cancer cells [40, 41]. This evidence concerns the gene CEACAM6 and breast carcinoma.